106 related articles for article (PubMed ID: 548256)
1. Assessment of immunobiological effects induced by chemicals, drugs or food additives. I. Tier testing and screening approach.
Dean JH; Padarathsingh ML; Jerrells TR
Drug Chem Toxicol; 1979; 2(1-2):5-17. PubMed ID: 548256
[TBL] [Abstract][Full Text] [Related]
2. Immunotoxicology in the pharmaceutical industry.
Norbury KC
Environ Health Perspect; 1982 Feb; 43():53-9. PubMed ID: 7037389
[TBL] [Abstract][Full Text] [Related]
3. Present and future uses of mutagenicity tests for assessment of the safety of food additives.
Green S
J Environ Pathol Toxicol; 1977; 1(2):49-54. PubMed ID: 121932
[TBL] [Abstract][Full Text] [Related]
4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
5. [Perspectives of immunopharmacology].
de Weck AL
Schweiz Rundsch Med Prax; 1985 Feb; 74(6):107-9. PubMed ID: 3975521
[No Abstract] [Full Text] [Related]
6. Procedures available to examine the immunotoxicity of chemicals and drugs.
Dean JH; Luster MI; Boorman GA; Lauer LD
Pharmacol Rev; 1982 Mar; 34(1):137-48. PubMed ID: 6280211
[TBL] [Abstract][Full Text] [Related]
7. Experiences with an advanced screening procedure for the identification of chemicals with an immunotoxic potential in routine toxicology.
Vohr HW
Toxicology; 1995 Dec; 104(1-3):149-58. PubMed ID: 8560493
[TBL] [Abstract][Full Text] [Related]
8. Assessment of in vivo assays for endocrine disruption.
Clode SA
Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):35-43. PubMed ID: 16522518
[TBL] [Abstract][Full Text] [Related]
9. The identification of chemicals with sensitizing or immunosuppressive properties in routine toxicology.
Basketter DA; Bremmer JN; Kammuller ME; Kawabata T; Kimber I; Loveless SE; Magda S; Pal TH; Stringer DA; Vohr HW
Food Chem Toxicol; 1994 Mar; 32(3):289-96. PubMed ID: 8157225
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results.
Borgert CJ; Mihaich EM; Quill TF; Marty MS; Levine SL; Becker RA
Regul Toxicol Pharmacol; 2011 Apr; 59(3):397-411. PubMed ID: 21251942
[TBL] [Abstract][Full Text] [Related]
11. A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships.
Johnson EM
Teratology; 1987 Jun; 35(3):405-27. PubMed ID: 3307013
[TBL] [Abstract][Full Text] [Related]
12. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
[TBL] [Abstract][Full Text] [Related]
13. Assessment of immunobiological effects induced by chemicals, drugs or food additives. II. Studies with cyclophosphamide.
Dean JH; Padarathsingh ML; Jerrells TR; Keys L; Northing JW
Drug Chem Toxicol; 1979; 2(1-2):133-53. PubMed ID: 317647
[No Abstract] [Full Text] [Related]
14. Immunotoxicity screening of drugs and chemicals: value of contact hypersensitivity to picryl chloride in the mouse.
Descotes J; Tedone R; Evreux JC
Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):303-5. PubMed ID: 4058100
[TBL] [Abstract][Full Text] [Related]
15. In vitro testing for direct immunotoxicity: state of the art.
Lankveld DP; Van Loveren H; Baken KA; Vandebriel RJ
Methods Mol Biol; 2010; 598():401-23. PubMed ID: 19967527
[TBL] [Abstract][Full Text] [Related]
16. Toxicogenomic approach to endocrine disrupters: identification of a transcript profile characteristic of chemicals with estrogenic activity.
Naciff JM; Daston GP
Toxicol Pathol; 2004; 32 Suppl 2():59-70. PubMed ID: 15503665
[TBL] [Abstract][Full Text] [Related]
17. [Methodological problems of screening immunotropic agents].
Uteshev BS
Farmakol Toksikol; 1984; 47(3):5-13. PubMed ID: 6610565
[TBL] [Abstract][Full Text] [Related]
18. A predictive index of biomarkers for ictogenesis from tier I safety pharmacology testing that may warrant tier II EEG studies.
Gauvin DV; Zimmermann ZJ; Yoder J; Harter M; Holdsworth D; Kilgus Q; May J; Dalton J; Baird TJ
J Pharmacol Toxicol Methods; 2018; 94(Pt 1):50-63. PubMed ID: 29751085
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis testing program.
Valcovic LR
Environ Health Perspect; 1977 Oct; 20():253-5. PubMed ID: 598350
[TBL] [Abstract][Full Text] [Related]
20. Assessment of dietary exposure in the French population to 13 selected food colours, preservatives, antioxidants, stabilizers, emulsifiers and sweeteners.
Bemrah N; Leblanc JC; Volatier JL
Food Addit Contam Part B Surveill; 2008; 1(1):2-14. PubMed ID: 24784532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
